Wall Street brokerages expect Wright Medical Group NV (NASDAQ:WMGI) to post earnings per share (EPS) of $0.16 for the current fiscal quarter, according to Zacks Investment Research. Fifteen analysts have made estimates for Wright Medical Group’s earnings. The lowest EPS estimate is $0.10 and the highest is $0.19. Wright Medical Group reported earnings per share of $0.11 in the same quarter last year, which would suggest a positive year-over-year growth rate of 45.5%. The firm is expected to issue its next earnings report on Tuesday, February 25th.
On average, analysts expect that Wright Medical Group will report full-year earnings of $0.17 per share for the current financial year, with EPS estimates ranging from $0.11 to $0.21. For the next year, analysts forecast that the company will post earnings of $0.44 per share, with EPS estimates ranging from $0.36 to $0.54. Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side research firms that cover Wright Medical Group.
Wright Medical Group (NASDAQ:WMGI) last announced its quarterly earnings data on Friday, November 8th. The medical device company reported ($0.05) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.01. The firm had revenue of $212.43 million for the quarter, compared to analyst estimates of $208.20 million. Wright Medical Group had a negative net margin of 14.49% and a positive return on equity of 1.89%.
In other news, SVP Julie Andrews sold 7,001 shares of Wright Medical Group stock in a transaction dated Friday, December 20th. The shares were sold at an average price of $30.10, for a total transaction of $210,730.10. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP James Lightman sold 188,868 shares of Wright Medical Group stock in a transaction dated Friday, November 15th. The stock was sold at an average price of $29.45, for a total transaction of $5,562,162.60. The disclosure for this sale can be found here. In the last ninety days, insiders sold 488,913 shares of company stock worth $14,417,744. Insiders own 3.80% of the company’s stock.
Several hedge funds and other institutional investors have recently modified their holdings of the company. Point72 Asset Management L.P. lifted its position in Wright Medical Group by 6,034.5% in the third quarter. Point72 Asset Management L.P. now owns 1,215,683 shares of the medical device company’s stock worth $25,080,000 after purchasing an additional 1,195,866 shares during the period. BlackRock Inc. grew its holdings in shares of Wright Medical Group by 4.8% during the 2nd quarter. BlackRock Inc. now owns 11,000,118 shares of the medical device company’s stock worth $328,024,000 after acquiring an additional 501,510 shares during the period. Marshall Wace North America L.P. purchased a new position in shares of Wright Medical Group during the 2nd quarter worth approximately $1,292,000. Envestnet Asset Management Inc. grew its holdings in shares of Wright Medical Group by 25.4% during the 3rd quarter. Envestnet Asset Management Inc. now owns 50,315 shares of the medical device company’s stock worth $1,038,000 after acquiring an additional 10,193 shares during the period. Finally, California Public Employees Retirement System grew its holdings in shares of Wright Medical Group by 53.9% during the 3rd quarter. California Public Employees Retirement System now owns 238,300 shares of the medical device company’s stock worth $4,916,000 after acquiring an additional 83,473 shares during the period.
Shares of WMGI traded up $0.01 during trading hours on Thursday, reaching $30.41. 33,248 shares of the company traded hands, compared to its average volume of 3,379,769. The stock has a market capitalization of $3.87 billion, a P/E ratio of 234.31, a P/E/G ratio of 4.74 and a beta of 0.94. The company has a quick ratio of 0.60, a current ratio of 0.86 and a debt-to-equity ratio of 0.86. Wright Medical Group has a 12-month low of $19.04 and a 12-month high of $32.86. The business has a fifty day moving average price of $29.96 and a 200-day moving average price of $25.49.
Wright Medical Group Company Profile
Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells upper and lower extremities, and biologics products in the United States, Europe, the Middle East, Africa, Canada, Asia, Australia, and Latin America. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth.
Featured Story: Profit Margin
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Wright Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.